On March 26th, SIMCERE PHARMA (02096) spent 22.0324 million Hong Kong dollars to repurchase 1.974 million shares.
Sinopharm Corporation (02096) announced that it will repurchase 1,974,000 shares at a cost of HKD 22.0324 million on March 26, 2026.
Simcere Pharma (02096) announced on March 26, 2026 that it has spent 22.0324 million Hong Kong dollars to repurchase 1.974 million shares.
Related Articles
YIDU TECH (02158) authorizes the trustee to purchase shares from the market based on the stock incentive plan.
SPT ENERGY (01251) announced its annual performance, with a net loss attributable to shareholders of 126 million yuan, a decrease of 50.87% compared to the previous year.
BOYAA (00434) spent HK$816,000 to repurchase 300,000 shares on March 26th.
YIDU TECH (02158) authorizes the trustee to purchase shares from the market based on the stock incentive plan.
SPT ENERGY (01251) announced its annual performance, with a net loss attributable to shareholders of 126 million yuan, a decrease of 50.87% compared to the previous year.
BOYAA (00434) spent HK$816,000 to repurchase 300,000 shares on March 26th.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
